Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Scheller

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 31, 2024
In vivo biocompatibility of a new hydrophobic coated Al/Al<sub>2</sub>O<sub>3</sub> nanowire surface on stentsAxel Rentzsch, Eva Metz, Ruben Mühl-Benninghaus, et al.
Circulation. Cardiovascular Interventions|September 20, 2022
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis LesionsBruno Scheller, Norman Mangner, Muhamad Ali S K Abdul Kader, et al.
American Heart Journal|November 14, 2017
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysisJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trialsMina Madan, Sigrun Halvorsen, Carlo Di Mario, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 13, 2016
Anatomical and procedural determinants of catheter-based renal denervationSebastian Ewen, Christian Ukena, Thomas Felix Lüscher, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 31, 2024
In vivo biocompatibility of a new hydrophobic coated Al/Al<sub>2</sub>O<sub>3</sub> nanowire surface on stentsAxel Rentzsch, Eva Metz, Ruben Mühl-Benninghaus, et al.
Circulation. Cardiovascular Interventions|September 20, 2022
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis LesionsBruno Scheller, Norman Mangner, Muhamad Ali S K Abdul Kader, et al.
American Heart Journal|November 14, 2017
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysisJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trialsMina Madan, Sigrun Halvorsen, Carlo Di Mario, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 13, 2016
Anatomical and procedural determinants of catheter-based renal denervationSebastian Ewen, Christian Ukena, Thomas Felix Lüscher, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
Pageof 20